Patients with Alzheimer’s disease (AD) and frontotemporal dementia exhibit pronounced neurovascular alterations early in the disease course4–7, suggesting that pathogenic drivers of neurodegeneration, such as amyloid-β and the microtubule-associated protein tau, may exert their deleterious effects also by impairing vascular function. The gene discussed is MAPT; the disease is Alzheimer disease.